It is expected that the redevelopment of the notifiable diseases surveillance system and its linkage with the vaccinations register will enhance the Unit’s capacity for early detection of clusters, early response to outbreaks, optimised number of averted new cases minimised complication rates.

The redevelopment of the immunisation register will enable and assessment of vaccine effectiveness, improve the reminder system and timely detection of high-risk children, thus assisting in profile identification and program planning.

The redevelopment of the dangerous drugs database will lead to better control of prescription drugs and proactive monitoring to minimise abuse and evaluate compliance with legislation.

The use of standard indigenous categories across data collections and service providers will improve accuracy and quality of the data collected so that identification of true indigenous health trends can inform targeted interventions.

The improved documentation, electronic data transfer and linkage of the cervical and breast cancer screening registers will assist early cancer detection and quality assurance in diagnosis and management.